Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA is warning healthcare providers, laboratory personnel, lab test developers and the public that biotin, vitamin B7, may interfere with laboratory tests and cause incorrect test results.
Gilead Sciences, a biopharmaceutical company based in Foster City, Calif., launched its hepatitis C drug in China with a price tag significantly lower than in the U.S., according to Caixin Global.
CVS Health's pharmacy benefits manager CVS Caremark, launched its "real-time benefits" tool to increase price transparency across all points of care.
How a structured assessment can help you identify supply chain improvement opportunities
Thomas M. Redding, Managing Director, Healthcare Services, St. Onge Company
Hospitals markup brand-name drugs nearly 487 percent, according to a study performed by The Moran Company and commissioned by Pharmaceutical Research and Manufacturers of America.
Sun Pharmaceutical Industries recalled two lots of the diabetes drug Riomet over contamination issues.
Here are six articles Becker's Hospital Review published in the last week, highlighting the top healthcare supply chains and the FDA's efforts to mitigate the national saline bag shortage, among other topics.
The Food and Drug Administration in October sent criminal investigation agents to nine locations across Central Florida that help customers order discount drugs from Canadian pharmacies and other foreign locations, according to a Kaiser Health News report.
The Food and Drug Administration approved a new version of kaléo's epinephrine auto-injector, Auvi-Q, specifically designed for children.
Roche Holding AG sued Pfizer in a move to prevent a biosimilar version of its breast cancer drug Herceptin from entering the U.S. market, according to Bloomberg.